Showing results (111-120 of 1,083) with videos related to

Sort By:
Pageof 109
Diabetes & Vascular Disease Research|October 6, 2010
Platelet abnormalities in diabetes mellitusJosé Luis Ferreiro, Joan Antoni Gómez-Hospital, Dominick J Angiolillo
Expert Opinion on Pharmacotherapy|October 22, 2008
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical developmentDominick J Angiolillo, Siva Suryadevara, Piera Capranzano, et al.
Expert Opinion on Drug Safety|November 6, 2025
Long-term safety of oral antiplatelet strategies for patients with acute coronary syndrome undergoing percutaneous coronary interventionClaudio Laudani, Luis Ortega-Paz, Davide Capodanno, et al.
Journal of Cardiovascular Translational Research|February 14, 2013
Platelet function profiles in patients with diabetes mellitusFabiana Rollini, Francesco Franchi, Ana Muñiz-Lozano, et al.
Journal of the American Heart Association|November 24, 2020
Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic ManagementLuis Ortega-Paz, Davide Capodanno, Gilles Montalescot, et al.
Cardiovascular Radiation Medicine|August 24, 2004
Intracoronary brachytherapy following drug-eluting stent failure. It's still not time to hang up the spikes!Dominick J Angiolillo, Manel Sabaté, Pilar Jiménez-Quevedo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcomeSilvia Gómez-Moreno, Manel Sabaté, Pilar Jiménez-Quevedo, et al.
Revista Espanola De Cardiologia|May 21, 2004
[Inflammation in acute coronary syndromes: mechanisms and clinical implications]Dominick J Angiolillo, Luigi M Biasucci, Giovanna Liuzzo, et al.
Expert Opinion on Investigational Drugs|November 1, 2018
CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarctionDavide Capodanno, Roxana Mehran, C Michael Gibson, et al.
Journal of Thrombosis and Thrombolysis|December 26, 2013
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studiesDominick J Angiolillo, Catherine Datto, Shane Raines, et al.
Pageof 109